| Literature DB >> 24614687 |
A Stevens1, C Bonshek1, A Whatmore1, I Butcher1, D Hanson1, C De Leonibus1, G Shaikh2, M Brown3, E O'Shea1, S Victor4, P Powell5, P Settle6, B Padmakumar7, A Tan7, E Odeka7, C Cooper8, J Birch9, A Shenoy10, M Westwood11, L Patel1, B W Dunn3, P Clayton1.
Abstract
Small for gestational age (SGA) children exhibiting catch-up (CU) growth have a greater risk of cardiometabolic diseases in later life compared with non-catch-up (NCU) SGA children. The aim of this study was to establish differences in metabolism and gene expression profiles between CU and NCU at age 4-9 years. CU children (n=22) had greater height, weight and body mass index standard deviation scores along with insulin-like growth factor-I (IGF-I) and fasting glucose levels but lower adiponectin values than NCU children (n=11; all P<0.05). Metabolic profiling demonstrated a fourfold decrease of urine myo-inositol in CU compared with NCU (P<0.05). There were 1558 genes differentially expressed in peripheral blood mononuclear cells between the groups (P<0.05). Integrated analysis of data identified myo-inositol related to gene clusters associated with an increase in insulin, growth factor and IGF-I signalling in CU children (P<0.05). Metabolic and transcriptomic profiles in CU SGA children showed changes that may relate to cardiometabolic risk.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24614687 DOI: 10.1038/tpj.2014.4
Source DB: PubMed Journal: Pharmacogenomics J ISSN: 1470-269X Impact factor: 3.550